Steris STE
NYSE STE
$236.15 -0.76 (-0.32%)
At close: Aug 20, 2026 · 2:57 PM UTC

Steris (STE) Cash from Financing Activities (2018 - 2026)

Steris (STE) posted quarterly Cash from Financing Activities of -$97.9 million for Q1 2026, up 45.03% year-over-year from -$67.5 million in Q1 2025, and little changed quarter-over-quarter from -$98.0 million in Q4 2025.

Steris (STE) Cash from Financing Activities (2018 - 2026) Analysis & Trends

Steris' Cash from Financing Activities history runs 9 years deep, the most recent figure standing at -$97.9 million for Q1 2026.

  • In Q1 2026, Cash from Financing Activities rose 45.03% year-over-year to -$97.9 million; the TTM figure through Mar 2026 stood at -$568.2 million (up 63.86% YoY), while the FY2026 annual figure was -$568.2 million, up 63.86% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at -$97.9 million, roughly flat from -$98.0 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $470.2 million in Q3 2023, with the low at -$998.9 million in Q2 2024.
  • The 5-year median for Cash from Financing Activities is -$178.1 million (2025), against an average of -$176.4 million.
  • The sharpest annual moves came in 2023 and 2024: Cash from Financing Activities surged 1146.13% in 2023, then tumbled 367.57% in 2024.
  • Steris' Cash from Financing Activities stood at -$120.4 million in 2022, then tumbled by 64.43% to -$198.0 million in 2023, then dropped by 8.29% to -$214.4 million in 2024, then jumped by 54.29% to -$98.0 million in 2025, then increased by 0.1% to -$97.9 million in 2026.
  • Business Quant data shows STE's Cash from Financing Activities at -$97.9 million in Q1 2026, -$98.0 million in Q4 2025, and -$159.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 199.75 Bn 194.14 Bn 7.27 Bn -3.52 Bn
2 Stryker 127.36 Bn 123.88 Bn 4.50 Bn -95.00 Mn
3 Medtronic 118.98 Bn 109.76 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 73.20 Bn 72.66 Bn 3.85 Bn -410.00 Mn
5 Edwards Lifesciences 52.10 Bn 47.85 Bn 1.35 Bn -300,000.00
6 Dexcom 34.32 Bn 32.37 Bn 830.00 Mn -607.30 Mn
7 GE HealthCare Technologies 33.77 Bn 31.66 Bn 2.18 Bn -236.00 Mn
8 Koninklijke Philips 26.36 Bn 23.04 Bn 4.55 Bn -1.34 Bn
9 Steris 23.04 Bn 22.56 Bn 684.20 Mn -213.50 Mn
10 Zimmer Biomet Holdings 19.20 Bn 18.79 Bn 1.54 Bn -271.10 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -213.50 Mn
Jun 30, 2026 -213.50 Mn
Mar 31, 2026 -97.90 Mn
Mar 31, 2026 -97.90 Mn
Dec 31, 2025 -98.00 Mn
Dec 31, 2025 -98.00 Mn
Sep 30, 2025 -159.20 Mn
Sep 30, 2025 -159.20 Mn
Jun 30, 2025 -213.10 Mn
Jun 30, 2025 -213.10 Mn
Mar 31, 2025 -178.10 Mn
Mar 31, 2025 -178.10 Mn
Dec 31, 2024 -214.40 Mn
Dec 31, 2024 -214.40 Mn
Sep 30, 2024 -181.00 Mn
Sep 30, 2024 -181.00 Mn
Jun 30, 2024 -998.90 Mn
Jun 30, 2024 -998.90 Mn
Mar 31, 2024 -143.78 Mn
Mar 31, 2024 -143.78 Mn